Publicacions en què col·labora amb Ana Rojo Sebastián (14)

2018

  1. Gamma-aminobutyric acid (GABA) receptors genes polymorphisms and risk for restless legs syndrome

    Pharmacogenomics Journal, Vol. 18, Núm. 4, pp. 565-577

2017

  1. Association between the rs1229984 polymorphism in the alcohol dehydrogenase 1B gene and risk for restless legs syndrome

    Sleep, Vol. 40, Núm. 12

  2. Thr105Ile (rs11558538) polymorphism in the histamine-1-methyl-transferase (HNMT) gene and risk for restless legs syndrome

    Journal of Neural Transmission, Vol. 124, Núm. 3, pp. 285-291

2015

  1. Neuronal nitric oxide synthase (nNOS, NOS1) rs693534 and rs7977109 variants and risk for restless legs syndrome

    Journal of Neural Transmission, Vol. 122, Núm. 6, pp. 819-823

  2. Association between Vitamin D receptor rs731236 (Taq1) polymorphism and risk for restless legs syndrome in the Spanish caucasian population

    Medicine (United States), Vol. 94, Núm. 47, pp. e2125

  3. Heme Oxygenase-1 and 2 Common Genetic Variants and Risk for Restless Legs Syndrome

    Medicine (United States), Vol. 94, Núm. 34, pp. e1448

2014

  1. The solute carrier family 1 (glial high affinity glutamate transporter), member 2 gene, SLC1A2, rs3794087 variant and assessment risk for restless legs syndrome

    Sleep Medicine, Vol. 15, Núm. 2, pp. 266-268

2013

  1. Dopamine receptor D3 (DRD3) gene rs6280 variant and risk for restless legs syndrome

    Sleep Medicine

  2. MAPT1 gene rs1052553 variant is unrelated with the risk for restless legs syndrome

    Journal of Neural Transmission, Vol. 120, Núm. 3, pp. 463-467

  3. Suicidal ideation in a European Huntington's disease population

    Journal of Affective Disorders, Vol. 151, Núm. 1, pp. 248-258

  4. β-defensin genomic copy number does not influence the age of onset in huntington’s disease

    Journal of Huntington's Disease, Vol. 2, Núm. 1, pp. 107-124

2012

  1. Discrepancies in reporting the CAG repeat lengths for Huntington’s disease

    European Journal of Human Genetics, Vol. 20, Núm. 1, pp. 20-26

2011

  1. NMDA receptor gene variations as modifiers in Huntington disease: A replication study

    PLoS Currents

2006

  1. A longitudinal study of patients with Parkinson's disease (ELEP): Aims and methodology

    Revista de Neurologia, Vol. 42, Núm. 6, pp. 360-365